Geode Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
99,457
+13,629
| +16% | +$247K | ﹤0.01% | 3176 |
|
|
2025
Q1 | $1.76M | Sell |
85,828
-2,716
| -3% | -$55.6K | ﹤0.01% | 3092 |
|
|
2024
Q4 | $2.28M | Buy |
88,544
+2,222
| +3% | +$57.1K | ﹤0.01% | 3084 |
|
|
2024
Q3 | $1.43M | Buy |
86,322
+1,399
| +2% | +$23.2K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $1.63M | Buy |
84,923
+32,738
| +63% | +$629K | ﹤0.01% | 3171 |
|
|
2024
Q1 | $1.23M | Buy |
52,185
+4,861
| +10% | +$115K | ﹤0.01% | 3285 |
|
|
2023
Q4 | $529K | Buy |
47,324
+5,516
| +13% | +$61.6K | ﹤0.01% | 3595 |
|
|
2023
Q3 | $387K | Buy |
41,808
+16,040
| +62% | +$148K | ﹤0.01% | 3696 |
|
|
2023
Q2 | $306K | Buy |
25,768
+7,209
| +39% | +$85.7K | ﹤0.01% | 3846 |
|
|
2023
Q1 | $249K | Buy |
+18,559
| New | +$249K | ﹤0.01% | 3938 |
|